Company Profile
Profile: UCB Asia Pacific Sdn Bhd is a global biopharma focusing on severe diseases in two therapeutic areas - CNS and Immunology. Our product line include Vimpat® (lacosamide)epilepsy, Keppra® (levetiracetam)epilepsy, Neupro® (rotigotine)parkinson's disease and restless legs syndrome. Keppra is indicated as a monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy The Keppra is indicated as an adjunctive therapy for partial onset seizures with or without secondary generalisation in adults, children and infants from 1 month of age with epilepsy.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Choline Chloride |
Ethanaminium,2-hydroxy-N,N,N-trimethyl-,chloride (1:1);Choline,chloride;Ethanaminium,2-hydroxy-N,N,N-trimethyl-,chloride;Biocolina;Hepacholine;(2-Hydroxyethyl)trimethylammonium chloride;Lipotril;Cholinium chloride;(β-Hydroxyethyl)trimethylammonium chloride;Bilineurin chloride;Luridin chloride;Biocoline;Hormocline;Neocolina;Paresan;Trimethyl(2-hydroxyethyl)ammonium chloride;Actiron CC 6;Choline chloride;Norcol 25;COL 24;ReaShure Choline;Claytreat;(2-Hydroxyethyl)trimethylazanium chloride;1643859-93-1;2028303-08-2 |
67-48-1 | Inquiry |
CONTACT INFORMATION
Sign In for Details